Experience with tocilizumab in patients with rheumatoid arthritis (according to the data of the LORNET multicenter trial)

Experience with tocilizumab in patients with rheumatoid arthritis (according to the data of the LORNET multicenter trial)

Objective: to estimate quality of life changes in patients with rheumatoid arthritis (RA) while adding tocilizumab (TCZ) to therapy with disease-modifying antirheumatic drugs (DMARDs) and to study the efficiency and safety of the therapy in RA patients with an inadequate response to previous DMARD t...

Full description

Bibliographic Details
Main Authors: E Yu Panasyuk, V N Amirdzhanova, Anastasia Sergeyevna Avdeyeva, E L Luchikhina, E N Aleksandrova, A A Novikov, E L Nasonov
Format: Article
Language:Russian
Published: IMA-PRESS LLC 2013-04-01
Series:Научно-практическая ревматология
Subjects:
das28
sdai
rheumatoid arthritis
tocilizumab
quality of life
remission
Online Access:https://rsp.mediar-press.net/rsp/article/view/773

Internet

https://rsp.mediar-press.net/rsp/article/view/773

Similar Items